Thermotherapy and hyperthermia for therapy of patients with prostatic hyperplasia
Tokumitsu, M.; Kaneko, S.; Yachiku, S.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 11): 397-401
2002
ISSN/ISBN: 0047-1852 PMID: 12599608 Document Number: 550301
Document emailed within 1 workday
Related Documents
Kinn, A.C.; Wiksell, H. 1993: Thermotherapy in prostatic hyperplasia Lakartidningen 90(11): 1037-1038; 1041Murayama, K.; Hisada, K. 2000: Transurethral microwave thermotherapy for benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 46(11): 799-802
Ramsey, E.W. 1995: Transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia Surgical Technology International Iv: 261-265
Umeda, H.; Yoshimura, Y.; Yamaguchi, O.; Kumakawa, K.; Shiraiwa, Y. 1997: Transurethral balloon laser thermotherapy for benign prostatic hyperplasia Hinyokika Kiyo. Acta Urologica Japonica 43(6): 415-419
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Spivak, L.G.; Lokshin, K.L.; Vinarov, A.Z. 2015: Review of Clinical Studies on Combination Therapy of 5α-Reductase Inhibitors and Α1-Blockers in Patients with Benign Prostatic Hyperplasia Urologiia 2015(4): 125-133
Sivkov, A.V.; Egorov, A.A.; Romikh, V.V.; Surikov, V.N. 2002: Urodynamic criteria of predicting efficacy of therapy with alpha1-adrenergic blockaders in patients with benign prostatic hyperplasia Urologiia 2002(5 Suppl): 13-22
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Bichler, K.H.; Wilbert, D.M.; Strohmaier, W.L. 1992: Hyperthermia and thermotherapy of the prostate--state and value Der Urologe. Ausg. a 31(1): 58-61
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Goldfarb, B.; Bartkiw, T.; Trachtenberg, J. 1995: Microwave therapy of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 431-439
Ekman, P. 1992: Drug therapy of benign prostatic hyperplasia Lakartidningen 89(45): 3803-3804
Trinkler, F.B. 1997: Therapy of benign prostatic hyperplasia: terazosin or finasteride? Praxis 86(34): 1305-1306
Madersbacher, S.; Marberger, M. 1996: Minimal invasive therapy of benign prostatic hyperplasia Wiener Medizinische Wochenschrift 146(8): 169-175
Hanus, M.; Matousková, M. 1993: Antiestrogens (tamoxifen) in the alternative therapy of benign prostatic hyperplasia Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 72(7): 316-318
Drsata, J. 2002: Enzyme inhibition in the drug therapy of benign prostatic hyperplasia Casopis Lekaru Ceskych 141(20): 630-635
Effert, P.; Ackermann, R. 1992: Clinical manifestations and indications for therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 31(3): 135-141
Savage, S.J..; Spungen, A.M..; Galea, G.; Britanico, J.; Vapnek, J.M.. 1998: Combination medical therapy for symptomatic benign prostatic hyperplasia Canadian Journal of Urology 5(3): 578-584
Von Ardenne, M.; Reitnauer, P.G. 1971: In vitro study for shortening of hyperthermia duration in multi-step cancer therapy. Release of lysosomal cytolysis chain reaction by over-acidification and hyperthermia and its continuation after cessation of hyperthermia Archiv für Geschwulstforschung 38(3): 264-269